Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 11/20 | 0.52 |
| ▸ | XDH | P47989 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.40 |
| ▸ | CTSD | P07339 | 3/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3686913 | 0.90 | MMP13 (0.58) | MMP13CTSDAGTR1ROCK2ROCK1 | |
| SCHEMBL8056484 | 0.88 | MMP13 (0.53) | MMP13ROCK2ROCK1 | |
| SCHEMBL8055185 | 0.86 | MMP13 (0.54) | MMP13XDHKDM4CEPHX2NR1H4 | |
| SCHEMBL3690556 | 0.84 | MMP13 (0.44) | MMP13XDHKDM4CEPHX2NR1H4 | |
| SCHEMBL3696323 | 0.84 | MMP13 (0.44) | MMP13XDHKDM4CEPHX2NR1H4 | |
| SCHEMBL8069852 | 0.84 | MMP13 (0.47) | MMP13XDHKDM4CEPHX2NR1H4 | |
| SCHEMBL8058261 | 0.84 | MMP13 (0.51) | MMP13XDHAGTR1ROCK2ROCK1 | |
| SCHEMBL8055078 | 0.80 | MMP13 (0.47) | MMP13ROCK2ROCK1 | |
| SCHEMBL8066347 | 0.79 | MMP13 (0.47) | MMP13ROCK2ROCK1 | |
| SCHEMBL8065771 | 0.78 | MMP13 (0.51) | MMP13XDHCTSDROCK2ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009016498-A1 | PYRIMIDINE AND PYRIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS | PFIZER INC. (US) | 2009-02-05 | — | — | WO | disclosed |